13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001599882
申报总市值
US$10.6亿
US$10.6亿
92 檔
16.3%
截至 Q4 2024 季度末，Rhenman & Partners Asset Management AB 的美股持仓估值约为 US$10.6亿，全数申报仓位共有 92 档。
在 Q4 2024，Rhenman & Partners Asset Management AB 展现出较为审慎的避险与获利了结姿态。本季共减仓 54 个仓位并完全清仓 5 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Rhenman & Partners Asset Management AB 的前 5 大核心持股（包含 BSX, LLY, PRCT 等）合计占整体申报市值的 16.3%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSX | Boston Scientific CORP | 股票-医疗保健 | 4.08% | -3.03% | -24.75% | |
| 2 | LLY | Eli Lilly & Co | 股票-医疗保健 | 3.61% | -1.30% | -4.32% | |
| 3 | PRCT | Procept Biorobotics CORP | 股票-其他 | 3.48% | -0.73% | -5.54% | |
| 4 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.43% | -0.80% | +1.59% | |
| 5 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 3.18% | -2.98% | +11.43% | |
| 6 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 3.15% | +2.15% | -16.74% | |
| 7 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 2.86% | — | +22.98% | |
| 8 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 2.84% | +2.59% | NEW | |
| 9 | EXK | Exact Sciences CORP | 股票-原材料 | 2.72% | — | +1.29% | |
| 10 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 2.56% | +0.24% | -10.70% | |
| 11 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 2.43% | -0.75% | -30.29% | |
| 12 | ABBV | Abbvie Inc | 股票-医疗保健 | 2.27% | +0.38% | -29.86% | |
| 13 | CI | THE Cigna Group | 股票-医疗保健 | 2.22% | +0.19% | +88.04% | |
| 14 | MDT | Medtronic plc | 股票-医疗保健 | 2.21% | +0.11% | -26.77% | |
| 15 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 2.07% | -0.96% | +4.71% | |
| 16 | ALHC | Alignment Healthcare Inc | 股票-其他 | 2.04% | -0.05% | -10.93% | |
| 17 | NTRA | Natera Inc | 股票-医疗保健 | 2.01% | +0.29% | -46.58% | |
| 18 | MCK | Mckesson CORP | 股票-医疗保健 | 2.00% | -0.62% | +13.28% | |
| 19 | BIIB | Biogen Inc | 股票-医疗保健 | 1.94% | -0.54% | +84.35% | |
| 20 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 1.88% | +0.13% | -0.64% | |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 1.84% | +0.22% | +56.45% | |
| 22 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 1.69% | +0.13% | -31.24% | |
| 23 | RPRX | Royalty Pharma plc | 股票-医疗保健 | 1.56% | -0.34% | -3.02% | |
| 24 | PODD | Insulet CORP | 股票-医疗保健 | 1.53% | +0.24% | +42.50% | |
| 25 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 1.51% | — | -14.36% | |
| 26 | DHR | Danaher CORP | 股票-医疗保健 | 1.51% | +1.02% | -23.23% | |
| 27 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.49% | -0.60% | -5.19% | |
| 28 | HUM | Humana Inc | 股票-医疗保健 | 1.44% | — | +78.16% | |
| 29 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 1.41% | -0.27% | +39.81% | |
| 30 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 1.35% | — | — | |
| 31 | COR | Cencora Inc | 股票-医疗保健 | 1.24% | -0.78% | +19.05% | |
| 32 | CVS | Cvs Health CORP | 股票-医疗保健 | 1.23% | -0.25% | +45.38% | |
| 33 | CNC | Centene CORP | 股票-医疗保健 | 1.22% | +1.48% | NEW | |
| 34 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 1.12% | — | -57.42% | |
| 35 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.10% | — | -29.48% | |
| 36 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 1.09% | -0.07% | -49.56% | |
| 37 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 1.07% | +0.13% | — | |
| 38 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.06% | — | -54.90% | |
| 39 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 1.02% | +0.47% | NEW | |
| 40 | IOVA | Iovance Biotherapeutics Inc | 股票-其他 | 0.94% | -0.22% | +17.38% | |
| 41 | JANX | Janux Therapeutics Inc | 股票-其他 | 0.94% | — | +59.11% | |
| 42 | ALGN | Align Technology Inc | 股票-医疗保健 | 0.90% | +0.84% | -23.82% | |
| 43 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.88% | +0.10% | -54.16% | |
| 44 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 0.84% | -1.02% | -37.69% | |
| 45 | SYK | Stryker CORP | 股票-医疗保健 | 0.83% | -0.01% | -2.17% | |
| 46 | TGTX | Tg Therapeutics Inc | 股票-医疗保健 | 0.81% | +0.03% | NEW | |
| 47 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 0.76% | -0.41% | +8.97% | |
| 48 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 0.72% | — | -17.31% | |
| 49 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 0.64% | — | -46.78% | |
| 50 | BNTX | Biontech Se-adr | 股票-其他 | 0.62% | — | +3.43% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ZBH | Zimmer Biomet Holdings Inc | +1.4% | NEW | 新建仓 |
| 2 | CI | THE Cigna Group | +1.1% | +88.04% | 加仓 |
| 3 | JAZZ | Jazz Pharmaceuticals plc | +1% | +56.45% | 加仓 |
| 4 | ISRG | Intuitive Surgical Inc | +0.9% | +1.59% | 加仓 |
| 5 | BIIB | Biogen Inc | +0.9% | +84.35% | 加仓 |
| 6 | MCK | Mckesson CORP | +0.8% | +13.28% | 加仓 |
| 7 | PODD | Insulet CORP | +0.8% | +42.50% | 加仓 |
| 8 | INSP | Inspire Medical Systems Inc | +0.8% | +22.98% | 加仓 |
| 9 | NBIX | Neurocrine Biosciences Inc | +0.7% | +39.81% | 加仓 |
| 10 | HUM | Humana Inc | +0.6% | +78.16% | 加仓 |
| 11 | MRK | Merck & Co. Inc. | +0.6% | +15.15% | 加仓 |
| 12 | PRCT | Procept Biorobotics CORP | +0.6% | -5.54% | 减仓 |
| 13 | JANX | Janux Therapeutics Inc | +0.6% | +59.11% | 加仓 |
| 14 | CNC | Centene CORP | +0.5% | +67.10% | 加仓 |
| 15 | TGTX | Tg Therapeutics Inc | +0.5% | +53.06% | 加仓 |
| 16 | UHS | Universal Health Services-b | +0.4% | +286.25% | 加仓 |
| 17 | COR | Cencora Inc | +0.4% | +19.05% | 加仓 |
| 18 | CVS | Cvs Health CORP | +0.3% | +45.38% | 加仓 |
| 19 | ITCIEUR | Intra-cellular Therapies Inc | +0.3% | -14.36% | 减仓 |
| 20 | VRTX | Vertex Pharmaceuticals Inc | +0.3% | +4.71% | 加仓 |
| 21 | ASTH | Astrana Health Inc | +0.3% | NEW | 新建仓 |
| 22 | ABT | Abbott Laboratories | +0.2% | -5.19% | 减仓 |
| 23 | LLY | Eli Lilly & Co | +0.2% | -4.32% | 减仓 |
| 24 | MOH | Molina Healthcare Inc | +0.2% | +15.54% | 加仓 |
| 25 | AXSM | Axsome Therapeutics Inc | +0.2% | — | 不变 |
| 26 | ESPR | Esperion Therapeutics Inc | +0.2% | -3.04% | 减仓 |
| 27 | SYK | Stryker CORP | +0.2% | -2.17% | 减仓 |
| 28 | EXK | Exact Sciences CORP | +0.2% | +1.29% | 加仓 |
| 29 | RPRX | Royalty Pharma plc | +0.2% | -3.02% | 减仓 |
| 30 | ALHC | Alignment Healthcare Inc | +0.1% | -10.93% | 减仓 |
| 31 | IOVA | Iovance Biotherapeutics Inc | +0.1% | +17.38% | 加仓 |
| 32 | KRYS | Krystal Biotech Inc | +0.1% | +39.71% | 加仓 |
| 33 | XNCR | Xencor Inc | +0.1% | -3.93% | 减仓 |
| 34 | IONS | Ionis Pharmaceuticals Inc | +0.1% | +8.97% | 加仓 |
| 35 | BNTX | Biontech Se-adr | +0.1% | +3.43% | 加仓 |
| 36 | ACLXGBX | Arcellx Inc | +0.1% | +35.94% | 加仓 |
| 37 | PRVA | Privia Health Group Inc | +0.1% | +27.31% | 加仓 |
| 38 | BSX | Boston Scientific CORP | +0.1% | -24.75% | 减仓 |
| 39 | EHC | Encompass Health CORP | +0.1% | -8.20% | 减仓 |
| 40 | ARVN | Arvinas Inc | +0.1% | +19.16% | 加仓 |
| 41 | PLRX | Pliant Therapeutics Inc | +0.1% | -3.33% | 减仓 |
| 42 | AVTR | Avantor Inc | 0% | +40.51% | 加仓 |
| 43 | MEDP | Medpace Holdings Inc | 0% | -9.33% | 减仓 |
| 44 | IMCR | Immunocore Holdings Plc-adr | 0% | — | 不变 |
| 45 | XENE | Xenon Pharmaceuticals Inc | 0% | — | 不变 |
| 46 | DVAX | Dynavax Technologies CORP | 0% | -29.48% | 减仓 |
| 47 | ANNX | Annexon Inc | 0% | -3.13% | 减仓 |
| 48 | KURA | Kura Oncology Inc | 0% | +88.88% | 加仓 |
| 49 | NRIX | Nurix Therapeutics Inc | 0% | -3.33% | 减仓 |
| 50 | RGEN | Repligen CORP | 0% | -10.00% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Rhenman & Partners Asset Management AB 在 Q4 2024 季度的美股持仓总市值约为 US$10.6亿，共申报了 92 个公开持股仓位。
在 Q4 2024 季度，Rhenman & Partners Asset Management AB 按市值排列的前三大核心持股分别为：BSX (4.1%)、LLY (3.6%)、PRCT (3.5%)。其中最大持股仓位 BSX 占据整体投资组合约 4.1% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
ZBH
市值: US$1309.8万
本季最大获利了结 / 清仓标的
EVH
前期市值: US$749.4万
在 Q4 2024 季度中，Rhenman & Partners Asset Management AB 共进行了 90 项持仓异动，包含新建仓 2 个仓位、加仓 29 个仓位、减仓 54 个仓位以及清仓 5 个仓位。 其中最大新建仓标的为 ZBH。 本季清仓仓位包含 EVH。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。